BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 233243)

  • 21. Review: prostaglandins and cancer.
    Karmali RA
    Prostaglandins Med; 1980 Jul; 5(1):11-28. PubMed ID: 6250176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypercalcemia with ovarian carcinoma: evidence of a pathogenetic role for prostaglandins.
    Josse RG; Wilson DR; Heersche JN; Mills JR; Murray TM
    Cancer; 1981 Sep; 48(5):1233-41. PubMed ID: 7272955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostaglandins and the hypercalcemia of cancer.
    Raisz LG
    N Engl J Med; 1973 Jul; 289(4):214-5. PubMed ID: 4712993
    [No Abstract]   [Full Text] [Related]  

  • 24. [Physiological and pharmacological actions of prostaglandins and related substances on mineral metabolism].
    Komori T; Morii H
    Nihon Rinsho; 1985 Mar; 43(3):537-43. PubMed ID: 2989585
    [No Abstract]   [Full Text] [Related]  

  • 25. Establishment of a parathyroid hormone-like factor-producing esophageal carcinoma cell line (EC-GI).
    Sato K; Kasono K; Ohba Y; Yashiro T; Fujii Y; Yoshida MA; Tsushima T; Shizume K
    Jpn J Cancer Res; 1987 Oct; 78(10):1044-8. PubMed ID: 2824416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gallium nitrate for treatment of refractory hypercalcemia from parathyroid carcinoma.
    Warrell RP; Issacs M; Alcock NW; Bockman RS
    Ann Intern Med; 1987 Nov; 107(5):683-6. PubMed ID: 2821862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parathyroid hormone-related protein and hypercalcemia.
    Rankin W; Grill V; Martin TJ
    Cancer; 1997 Oct; 80(8 Suppl):1564-71. PubMed ID: 9362423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulation of calcium reabsorption observed in advanced breast cancer patients with hypercalcemia and multiple bone metastases.
    Kimura S; Adchi I; Yamaguchi K; Suzuki M; Shimada A; Sato Y; Nagaoka K; Abe K
    Jpn J Cancer Res; 1985 Apr; 76(4):308-14. PubMed ID: 2989061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study of the effects of cyclic nucleotide phosphodiesterase inhibitors on bone resorption and cyclic AMP formation in vitro.
    Lerner U; Ransjö M; Fredholm BB
    Biochem Pharmacol; 1986 Dec; 35(23):4177-89. PubMed ID: 2431692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The tumor cells (FA-6) established from a pancreatic cancer associated with humoral hypercalcemia of malignancy: a simultaneous production of parathyroid hormone-like activity and transforming growth factor activity.
    Nagata N; Akatsu T; Kugai N; Yasutomo Y; Kinoshita T; Kosano H; Shimauchi T; Takatani O; Ueyama Y
    Endocrinol Jpn; 1989 Feb; 36(1):75-85. PubMed ID: 2543550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of phenytoin on parathyroid extract and 25-hydroxycholecalciferol-induced bone resorption: adenosine 3, 5 cyclic monophosphate production.
    Jenkins MV; Harris M; Wills MR
    Calcif Tissue Res; 1974; 16(2):163-7. PubMed ID: 4374992
    [No Abstract]   [Full Text] [Related]  

  • 32. Parathyroid hormone-related protein of malignancy: active synthetic fragments.
    Kemp BE; Moseley JM; Rodda CP; Ebeling PR; Wettenhall RE; Stapleton D; Diefenbach-Jagger H; Ure F; Michelangeli VP; Simmons HA
    Science; 1987 Dec; 238(4833):1568-70. PubMed ID: 3685995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostaglandins, bone resorption and hypercalcemia.
    Harris M; Jenkins MV; Bennett A; Wills MR
    N Engl J Med; 1973 Oct; 289(16):865. PubMed ID: 4763437
    [No Abstract]   [Full Text] [Related]  

  • 34. The effects of dichloromethylene diphosphonate on hypercalcemia and other parameters of the humoral hypercalcemia of malignancy in the rat Leydig cell tumor.
    Martodam RR; Thornton KS; Sica DA; D'Souza SM; Flora L; Mundy GR
    Calcif Tissue Int; 1983 Jul; 35(4-5):512-9. PubMed ID: 6311375
    [No Abstract]   [Full Text] [Related]  

  • 35. Humoral hypercalcemia of malignancy: a syndrome in search of a hormone.
    Gottleib S; Rude RK; Sharp CF; Singer FR
    Am J Med; 1982 Nov; 73(5):751-5. PubMed ID: 6291389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition by ouabain of parathyroid hormone-stimulated bone resorption.
    Krieger NS; Tashjian AH
    J Pharmacol Exp Ther; 1981 Jun; 217(3):586-91. PubMed ID: 6262491
    [No Abstract]   [Full Text] [Related]  

  • 37. Hypercalcaemia.
    Chisholm GD
    Prog Clin Biol Res; 1982; 100():293-300. PubMed ID: 7145951
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prostaglandins].
    Shiraki M; Kaneki M
    Nihon Rinsho; 1990 Dec; 48(12):2811-7. PubMed ID: 2086838
    [No Abstract]   [Full Text] [Related]  

  • 39. Hypercalcemia of malignancy: the central role of parathyroid hormone-related protein.
    Wysolmerski JJ; Broadus AE
    Annu Rev Med; 1994; 45():189-200. PubMed ID: 8198376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory action of pertussis toxin on parathyroid hormone and prostaglandin E2-stimulated bone resorption in cultured neonatal mouse calvaria.
    Ransjö M; Lerner UH
    Acta Physiol Scand; 1987 Oct; 131(2):315-7. PubMed ID: 2823535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.